Redox sensitivity of tyrosine Hydroxylase activity and expression in dopaminergic dysfunction

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 4, 2012, Pages 419-429

  Di Giovanni, Giuseppe ^a,b   Pessia, Mauro ^c   Di Maio, Roberto ^d,e  

^a UNIVERSITY OF MALTA   (Malta)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Istituto Mediterraneo per i Trapianti e Terapie (ISMETT) Ad Alta Specializzazione RIMED Foundation   (Italy)

Author keywords

Dopamine; Neurodegenaration; Parkinson's disease; Reactive oxygen species; Tyrosine hydroxylase

Indexed keywords

3 NITROTYROSINE; CYSTEINE; DISULFIDE; DOPAMINE; LEVODOPA; PEROXYNITRITE; TYROSINE 3 MONOOXYGENASE; ZINC FINGER PROTEIN;

AGING; BRAIN; CARBONYLATION; DEGENERATIVE DISEASE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; ENZYME METABOLISM; HYDROXYLATION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; REVIEW;

EID: 84862563824     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712800792938     Document Type: Review

References (123)

1. Shacter, E. Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev., 2000, 32(3/4), 307-326.
2. Jones, D.P.; Go, Y.M.; Anderson, C.L.; Ziegler, T.R.; Kinkade, J.M., Jr.; Kirlin, W.G. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J., 2004, 18(11), 1246-1248.
3. Schafer, F.Q.; Buettner, G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med., 2001, 30(11), 1191-1212.
4. Bader, M.; Muse, W.; Ballou, D.P.; Gassner, C.; Bardwell, J.C. Oxidative protein folding is driven by the electron transport system. Cell, 1999, 98(2), 217-227.
5. Paget, M.S.; Buttner, M.J. Thiol-based regulatory switches. Ann. Rev. Genet., 2003, 37, 91-121.
6. Stadtman, E.R. Protein oxidation in aging and age-related diseases. Ann. NY Acad. Sci., 2001, 928, 22-38.
7. Wong-Ekkabut, J.; Xu, Z.; Triampo, W.; Tang, I.M.; Tieleman, D.P.; Monticelli, L. Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys. J., 2007, 93(12), 4225-4236.
8. Halliwell, B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic. Res., 1999, 31(4), 261-272.
9. Mariani, E.; Polidori, M.C.; Cherubini, A.; Mecocci, P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2005, 827(1), 65-75.
10. Jellinger, K.A. General aspects of neurodegeneration. J. Neural Transm. Suppl., 2003, 65, 101-144.
11. Migliore, L.; Fontana, I.; Colognato, R.; Coppede, F.; Siciliano, G.; Murri, L. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiol. Aging, 2005, 26(5), 587-595.
12. Perry, G.; Nunomura, A.; Hirai, K.; Zhu, X.; Perez, M.; Avila, J.; Castellani, R.J.; Atwood, C.S.; Aliev, G.; Sayre, L.M.; Takeda, A.; Smith, M.A. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med., 2002, 33(11), 1475-1479.
13. Ashrafi, M.R.; Shams, S.; Nouri, M.; Mohseni, M.; Shabanian, R.; Yekaninejad, M.S.; Chegini, N.; Khodadad, A.; Safaralizadeh, R. A probable causative factor for an old problem: selenium and glutathione peroxidase appear to play important roles in epilepsy pathogenesis. Epilepsia, 2007, 48(9), 1750-1755.
14. Di Maio, R.; Mastroberardino, P.G.; Hu, X.; Montero, L.; Greenamyre, J.T. Pilocapine alters NMDA receptor expression and function in hippocampal neurons: NADPH oxidase and ERK1/2 mechanisms. Neurobiol. Dis., 2011, 42(3), 482-495.
15. Esposito, E.; Di Matteo, V.; Di Giovanni, G. Death in the substantia nigra: a motor tragedy. Expert Rev. Neurother., 2007, 7(6), 677-697.
16. Rinne, J.O. Nigral degeneration in Parkinson's disease. Mov. Disord. 1993, 8(Suppl 1), S31-S35.
17. Bjorklund, A.; Dunnett, S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci., 2007, 30(5), 194-202.
18. Bonci, A.; Grillner, P.; Mercuri, N.B.; Bernardi, G. L-Type calcium channels mediate a slow excitatory synaptic transmission in rat midbrain dopaminergic neurons. J. Neurosci., 1998, 18(17), 6693-6703.
19. Nedergaard, S.; Flatman, J.A.; Engberg, I. Nifedipine- and omegaconotoxin- sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. J. Physiol., 1993, 466, 727-747.
20. Puopolo, M.; Raviola, E.; Bean, B.P. Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J. Neurosci., 2007, 27(3), 645-656.
21. Chan, C.S.; Gertler, T.S.; Surmeier, D.J. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease. Mov. Disord., 2010, 25(Suppl 1), S63-S70.
22. Chan, C.S.; Guzman, J.N.; Ilijic, E.; Mercer, J.N.; Rick, C.; Tkatch, T.; Meredith, G.E.; Surmeier, D.J. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature, 2007, 447(7148), 1081-1086.
23. Jenner, P.; Olanow, C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology, 1996, 47(6 Suppl 3), S161-170.
24. Betarbet, R.; Sherer, T.B.; MacKenzie, G.; Garcia-Osuna, M.; Panov, A.V.; Greenamyre, J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci., 2000, 3(12), 1301-1306.
25. McCormack, A.L.; Thiruchelvam, M.; Manning-Bog, A.B.; Thiffault, C.; Langston, J.W.; Cory-Slechta, D.A.; Di Monte, D.A. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis., 2002, 10(2), 119-127.
26. Di Matteo, V.; Pierucci, M.; Di Giovanni, G.; Di Santo, A.; Poggi, A.; Benigno, A.; Esposito, E. Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study. Brain Res., 2006, 1095(1), 167-177.
27. Zigmond, R.E.; Schwarzschild, M.A.; Rittenhouse, A.R. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Ann. Rev. Neurosci., 1989, 12, 415-461.
28. Haycock, J.W. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem., 1990, 265(20), 11682-11691.
29. Fitzpatrick, P.F. Tetrahydropterin-dependent amino acid hydroxylases. Ann. Rev., Biochem., 1999, 68, 355-381.
30. Kumer, S.C.; Vrana, K.E. Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem., 1996, 67(2), 443-462.
31. Ischiropoulos, H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem. Biophys. Res. Commun., 2003, 305(3), 776-783.
32. Good, P.F.; Hsu, A.; Werner, P.; Perl, D.P.; Olanow, C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol., 1998, 57(4), 338-342.
33. Torreilles, F.; Salman-Tabcheh, S.; Guerin, M.; Torreilles, J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev., 1999, 30(2), 153-163.
34. Ara, J.; Przedborski, S.; Naini, A.B.; Jackson-Lewis, V.; Trifiletti, R.R.; Horwitz, J.; Ischiropoulos, H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. USA, 1998, 95(13), 7659-7663.
35. Blanchard-Fillion, B.; Souza, J.M.; Friel, T.; Jiang, G.C.; Vrana, K.; Sharov, V.; Barron, L.; Schoneich, C.; Quijano, C.; Alvarez, B.; Radi, R.; Przedborski, S.; Fernando, G.S.; Horwitz, J.; Ischiropoulos, H. Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. J. Biol. Chem., 2001, 276(49), 46017-46023.
36. Sadidi, M.; Geddes, T.J.; Kuhn, D.M. S-thiolation of tyrosine hydroxylase by reactive nitrogen species in the presence of cysteine or glutathione. Antioxid. Redox Signal., 2005, 7(7-8), 863-869.
37. Dunkley, P.R.; Bobrovskaya, L.; Graham, M.E.; von Nagy-Felsobuki, E.I.; Dickson, P.W. Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem., 2004, 91(5), 1025-1043.
38. Chetsawang, B.; Chetsawang, J.; Govitrapong, P. Protection against cell death and sustained tyrosine hydroxylase phosphorylation in hydrogen peroxide- and MPP-treated human neuroblastoma cells with melatonin. J. Pineal Res., 2009, 46(1), 36-42.
39. Klongpanichapak, S.; Phansuwan-Pujito, P.; Ebadi, M.; Govitrapong, P. Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells. Neurosci. Lett., 2008, 436(3), 309-313.
40. Singh, B.K.; Kumar, A.; Ahmad, I.; Kumar, V.; Patel, D.K.; Jain, S.K.; Singh, C. Oxidative stress in zinc-induced dopaminergic neurodegeneration: implications of superoxide dismutase and heme oxygenase-1. Free Radic. Res., 2011, 45(10), 1207-1222.
41. Ishikawa, S.; Taira, T.; Niki, T.; Takahashi-Niki, K.; Maita, C.; Maita, H.; Ariga, H.; Iguchi-Ariga, S.M. Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1. J. Biol. Chem., 2009, 284(42), 28832-28844.
42. MohanKumar, S.M.; Kasturi, B.S.; Shin, A.C.; Balasubramanian, P.; Gilbreath, E.T.; Subramanian, M.; Mohankumar, P.S. Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, 300(3), R693-R699.
43. Jenner, P. Oxidative stress in Parkinson's disease. Ann. Neurol., 2003, 53(Suppl 3), S26-S36; discussion S36-S38.
44. Horowitz, M.P.; Milanese, C.; Di Maio, R.; Hu, X.; Montero, L.M.; Sanders, L.H.; Tapias, V.; Sepe, S.; van Cappellen, W.A.; Burton, E.A.; Greenamyre, J.T.; Mastroberardino, P.G. Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults. Antioxid. Redox Signal., 2011, 15(4), 855-871.
45. Bodhinathan, K.; Kumar, A.; Foster, T.C. Intracellular redox state alters NMDA receptor response during aging through Ca2+/calmodulin-dependent protein kinase II. J. Neurosci., 2010, 30(5), 1914-1924.
46. Cai, S.Q.; Sesti, F. Oxidation of a potassium channel causes progressive sensory function loss during aging. Nat. Neurosci., 2009, 12(5), 611-617.
47. Gamper, N.; Zaika, O.; Li, Y.; Martin, P.; Hernandez, C.C.; Perez, M.R.; Wang, A.Y.; Jaffe, D.B.; Shapiro, M.S. Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing. EMBO J., 2006, 25(20), 4996-5004.
48. Wu, X.; Bishopric, N.H.; Discher, D.J.; Murphy, B.J.; Webster, K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell Biol., 1996, 16(3), 1035-1046.
49. Mastroberardino, P.G.; Hoffman, E.K.; Horowitz, M.P.; Betarbet, R.; Taylor, G.; Cheng, D.; Na, H.M.; Gutekunst, C.A.; Gearing, M.; Trojanowski, J.Q.; Anderson, M.; Chu, C.T.; Peng, J.; Greenamyre, J.T. A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol. Dis., 2009, 34(3), 417-431.
50. Adimora, N.J.; Jones, D.P.; Kemp, M.L. A model of redox kinetics implicates the thiol proteome in cellular hydrogen peroxide responses. Antioxid. Redox Signal., 2010, 13(6), 731-743.
51. Kemp, M.; Go, Y.M.; Jones, D.P. Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology. Free Radic. Biol. Med., 2008, 44(6), 921-937.
52. Yang, W.; Tiffany-Castiglioni, E. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J. Toxicol. Environ. Health A, 2005, 68(22), 1939-1961.
53. Sherer, T.B.; Betarbet, R.; Testa, C.M.; Seo, B.B.; Richardson, J.R.; Kim, J.H.; Miller, G.W.; Yagi, T.; Matsuno-Yagi, A.; Greenamyre, J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci., 2003, 23(34), 10756-10764.
54. Hawkins, C.L.; Davies, M.J. Generation and propagation of radical reactions on proteins. Biochim. Biophys. Acta, 2001, 1504(2/3), 196-219.
55. Stadtman, E.R.; Berlett, B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol., 1997, 10(5), 485-494.
56. Stadtman, E.R.; Oliver, C.N. Metal-catalyzed oxidation of proteins. Physiological consequences. J. Biol. Chem., 1991, 266(4), 2005-2008.
57. He, Y.; Imam, S.Z.; Dong, Z.; Jankovic, J.; Ali, S.F.; Appel, S.H.; Le, W. Role of nitric oxide in rotenone-induced nigro-striatal injury. J. Neurochem., 2003, 86(6), 1338-1345.
58. Haavik, J.; Flatmark, T. Isolation and characterization of tetrahydropterin oxidation products generated in the tyrosine 3- monooxygenase (tyrosine hydroxylase) reaction. Eur. J. Biochem., 1987, 168(1), 21-26.
59. Ramsey, A.J.; Fitzpatrick, P.F. Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines: evidence for a novel regulatory mechanism. Biochemistry, 1998, 37(25), 8980-8986.
60. Ramsey, A.J.; Fitzpatrick, P.F. Effects of phosphorylation on binding of catecholamines to tyrosine hydroxylase: specificity and thermodynamics. Biochemistry, 2000, 39(4), 773-778.
61. Barbosa, E.R.; Comerlatti, L.R.; Haddad, M.S.; Scaff, M. [Parkinsonism secondary to ethylene oxide exposure: case report. Arq. Neuropsiquiatr., 1992, 50(4), 531-533.
62. Muller-Vahl, K.R.; Kolbe, H.; Dengler, R. Transient severe parkinsonism after acute organophosphate poisoning. J. Neurol. Neurosurg. Psychiatry, 1999, 66(2), 253-254.
63. De La Cruz, C.P.; Revilla, E.; Venero, J.L.; Ayala, A.; Cano, J.; Machado, A. Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat. Free Radic. Biol. Med., 1996, 20(1), 53-61.
64. Wallace, D.C. Bioenergetic Origins of Complexity and Disease. Cold Spring Harb. Symp. Quant. Biol., 2011, [Epub ahead of print].
65. Borges, C.R.; Geddes, T.; Watson, J.T.; Kuhn, D.M. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J. Biol. Chem., 2002, 277(50), 48295-48302.
66. Park, S.; Geddes, T.J.; Javitch, J.A.; Kuhn, D.M. Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage? J. Biol. Chem., 2003, 278(31), 28736-28742.
67. Klatt, P.; Lamas, S. Regulation of protein function by Sglutathiolation in response to oxidative and nitrosative stress. Eur. J. Biochem., 2000, 267(16), 4928-4944.
68. Kuhn, D.M.; Geddes, T.J. Tetrahydrobiopterin prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide. Mol. Pharmacol., 2003, 64(4), 946-953.
69. Kuhn, D.M.; Geddes, T.J. Reduced nicotinamide nucleotides prevent nitration of tyrosine hydroxylase by peroxynitrite. Brain Res., 2002, 933(1), 85-89.
70. Kuhn, D.M.; Sakowski, S.A.; Sadidi, M.; Geddes, T.J. Nitrotyrosine as a marker for peroxynitrite-induced neurotoxicity: the beginning or the end of the end of dopamine neurons? J. Neurochem., 2004, 89(3), 529-536.
71. Franco, J.L.; Posser, T.; Gordon, S.L.; Bobrovskaya, L.; Schneider, J.J.; Farina, M.; Dafre, A.L.; Dickson, P.W.; Dunkley, P.R. Expression of tyrosine hydroxylase increases the resistance of human neuroblastoma cells to oxidative insults. Toxicol. Sci., 2009, 113(1), 150-157.
72. Kaushik, P.; Gorin, F.; Vali, S. Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. J. Comput. Neurosci., 2007, 22(2), 147-160.
73. Moy, L.Y.; Tsai, L.H. Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability. J. Biol. Chem., 2004, 279(52), 54487-54493.
74. Iida, Y.; Sawabe, K.; Kojima, M.; Oguro, K.; Nakanishi, N.; Hasegawa, H. Proteasome-driven turnover of tryptophan hydroxylase is triggered by phosphorylation in RBL2H3 cells, a serotonin producing mast cell line. Eur. J. Biochem., 2002, 269(19), 4780-4788.
75. Kawahata, I.; Tokuoka, H.; Parvez, H.; Ichinose, H. Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells. J. Neural Transm., 2009, 116(12), 1571-1578.
76. Winterbourn, C.C.; Hampton, M.B. Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med., 2008, 45(5), 549-561.
77. McCubrey, J.A.; Franklin, R.A. Reactive oxygen intermediates and signaling through kinase pathways. Antioxid. Redox Signal., 2006, 8(9/10), 1745-1748.
78. Agnati, L.F.; Fuxe, K.; Benfenati, F.; Zini, I.; Zoli, M.; Fabbri, L.; Harfstrand, A. Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects. Acta Physiol. Scand. Suppl., 1984, 532, 5-36.
79. Finch, C.E.; Morgan, D.G. RNA and protein metabolism in the aging brain. Ann. Rev. Neurosci., 1990, 13, 75-88.
80. Venero, J.L.; Machado, A.; Cano, J. Changes in monoamines and their metabolite levels in substantia nigra of aged rats. Mech. Ageing Dev., 1989, 49(3), 227-233.
81. Venero, J.L.; Machado, A.; Cano, J. Age effects on monoamine turnover of the rat substantia nigra. Brain Res., 1991, 557(1/2), 109-114.
82. McGeer, P.L.; Itagaki, S.; Akiyama, H.; McGeer, E.G. Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol., 1988, 24(4), 574-576.
83. McGeer, P.L.; McGeer, E.G.; Suzuki, J.S. Aging and extrapyramidal function. Arch. Neurol., 1977, 34(1), 33-35.
84. Allen, E.; Carlson, K.M.; Zigmond, M.J.; Cavanaugh, J.E. LDOPA reverses motor deficits associated with normal aging in mice. Neurosci. Lett., 2010, 489(1), 1-4.
85. Anandhan, A.; Tamilselvam, K.; Radhiga, T.; Rao, S.; Essa, M.M.; Manivasagam, T. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Res., 2011, 1433, 104-113.
86. Ahmad, S.; Khan, M.B.; Hoda, M.N.; Bhatia, K.; Haque, R.; Fazili, I.S.; Jamal, A.; Khan, J.S.; Katare, D.P. Neuroprotective Effect of Sesame Seed Oil in 6-Hydroxydopamine Induced Neurotoxicity in Mice Model: Cellular, Biochemical and Neurochemical Evidence. Neurochem. Res., 2011, 37(3), 516-526.
87. Huh, S.H.; Chung, Y.C.; Piao, Y.; Jin, M.Y.; Son, H.J.; Yoon, N.S.; Hong, J.Y.; Pak, Y.K.; Kim, Y.S.; Hong, J.K.; Hwang, O.; Jin, B.K. Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease. J. Immunol., 2011, 187(2), 960-969.
88. Sai, Y.; Wu, Q.; Le, W.; Ye, F.; Li, Y.; Dong, Z. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Toxicol. In Vitro, 2008, 22(6), 1461-1468.
89. Kim, Y.H.; Rane, A.; Lussier, S.; Andersen, J.K. Lithium protects against oxidative stress-mediated cell death in alpha-synucleinoverexpressing in vitro and in vivo models of Parkinson's disease. J. Neurosci. Res., 2011, 89(10), 1666-1675.
90. Banerjee, U.; Dasgupta, A.; Rout, J.K.; Singh, O.P. Effects of lithium therapy on Na(+)-K(+)-ATPase activity and lipid peroxidation in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2012, 37(1), 56-61.
91. Tan, H.; Young, L.T.; Shao, L.; Che, Y.; Honer, W.G.; Wang, J.F. Mood stabilizer lithium inhibits amphetamine-increased 4- hydroxynonenal-protein adducts in rat frontal cortex. Int. J. Neuropsychopharmacol., 2011, [Epub ahead of print]
92. Brandish, P.E.; Su, M.; Holder, D.J.; Hodor, P.; Szumiloski, J.; Kleinhanz, R.R.; Forbes, J.E.; McWhorter, M.E.; Duenwald, S.J.; Parrish, M.L.; Na, S.; Liu, Y.; Phillips, R.L.; Renger, J.J.; Sankaranarayanan, S.; Simon, A.J.; Scolnick, E.M. Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex. Neuron, 2005, 45(6), 861-872.
93. Willing, A.E.; Zigova, T.; Milliken, M.; Poulos, S.; Saporta, S.; McGrogan, M.; Snable, G.; Sanberg, P.R. Lithium exposure enhances survival of NT2N cells(hNT neurons) in the hemiparkinsonian rat. Eur. J. Neurosci., 2002, 16(12), 2271-2278.
94. Ferrie, L.; Young, A.H.; McQuade, R. Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat. Int. J. Neuropsychopharmacol., 2006, 9(6), 729-735.
95. Takeda, A. Movement of zinc and its functional significance in the brain. Brain Res. Brain Res. Rev., 2000, 34(3), 137-148.
96. Kumar, A.; Ahmad, I.; Shukla, S.; Singh, B.K.; Patel, D.K.; Pandey, H.P.; Singh, C. Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic. Res., 2010, 44(8), 950-965.
97. Kumar, A.; Singh, B.K.; Ahmad, I.; Shukla, S.; Patel, D.K.; Srivastava, G.; Kumar, V.; Pandey, H.P.; Singh, C. Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: Similarity with paraquat neurotoxicity. Brain Res., 2011, 1438, 48-64.
98. Dexter, D.T.; Carayon, A.; Javoy-Agid, F.; Agid, Y.; Wells, F.R.; Daniel, S.E.; Lees, A.J.; Jenner, P.; Marsden, C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain, 1991, 114(Pt 4), 1953-1975.
99. Lin, A.M.; Fan, S.F.; Yang, D.M.; Hsu, L.L.; Yang, C.H. Zincinduced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radic. Biol. Med., 2003, 34(11), 1416-1425.
100. Webster, K.A.; Discher, D.J.; Bishopric, N.H. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem., 1993, 268(22), 16852-16858.
101. Bauskin, A.R.; Alkalay, I.; Ben-Neriah, Y. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell, 1991, 66(4), 685-696.
102. Cowan, D.B.; Weisel, R.D.; Williams, W.G.; Mickle, D.A. The regulation of glutathione peroxidase gene expression by oxygen tension in cultured human cardiomyocytes. J. Mol. Cell Cardiol., 1992, 24(4), 423-433.
103. Wang, G.L.; Semenza, G.L. General involvement of hypoxiainducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA, 1993, 90(9), 4304-4308.
104. Rhodes, D.; Klug, A. Zinc fingers. Sci. Am., 1993, 268(2), 56-59.
105. Berg, J.M. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc. Natl. Acad. Sci. USA, 1992, 89(23), 11109-11110.
106. Desjarlais, J.R.; Berg, J.M. Toward rules relating zinc finger protein sequences and DNA binding site preferences. Proc. Natl. Acad. Sci. USA, 1992, 89(16), 7345-7349.
107. Kadonaga, J.T.; Carner, K.R.; Masiarz, F.R.; Tjian, R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 1987, 51(6), 1079-1090.
108. Gill, G.; Pascal, E.; Tseng, Z.H.; Tjian, R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc. Natl. Acad. Sci. USA, 1994, 91(1), 192-196.
109. Kim, S.J.; Onwuta, U.S.; Lee, Y.I.; Li, R.; Botchan, M.R.; Robbins, P.D. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell Biol., 1992, 12(6), 2455-2463.
110. Kingsley, C.; Winoto, A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol., 1992, 12(10), 4251-4261.
111. Ammendola, R.; Mesuraca, M.; Russo, T.; Cimino, F. The DNAbinding efficiency of Sp1 is affected by redox changes. Eur. J. Biochem., 1994, 225(1), 483-489.
112. Hentze, M.W.; Rouault, T.A.; Harford, J.B.; Klausner, R.D. Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science, 1989, 244(4902), 357-359.
113. Pognonec, P.; Kato, H.; Roeder, R.G. The helix-loop-helix/leucine repeat transcription factor USF can be functionally regulated in a redox-dependent manner. J. Biol. Chem., 1992, 267(34), 24563-24567.
114. Cookson, M.R. Pathways to Parkinsonism. Neuron, 2003, 37(1), 7-10.
115. Bonifati, V.; Rizzu, P.; van Baren, M.J.; Schaap, O.; Breedveld, G.J.; Krieger, E.; Dekker, M.C.; Squitieri, F.; Ibanez, P.; Joosse, M.; van Dongen, J.W.; Vanacore, N.; van Swieten, J.C.; Brice, A.; Meco, G.; van Duijn, C.M.; Oostra, B.A.; Heutink, P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 2003, 299(5604), 256-259.
116. Annesi, G.; Savettieri, G.; Pugliese, P.; D'Amelio, M.; Tarantino, P.; Ragonese, P.; La Bella, V.; Piccoli, T.; Civitelli, D.; Annesi, F.; Fierro, B.; Piccoli, F.; Arabia, G.; Caracciolo, M.; Ciro Candiano, I.C.; Quattrone, A. DJ-1 mutations and parkinsonism-dementiaamyotrophic lateral sclerosis complex. Ann. Neurol., 2005, 58(5), 803-807.
117. Abou-Sleiman, P.M.; Healy, D.G.; Quinn, N.; Lees, A.J.; Wood, N.W. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann. Neurol., 2003, 54(3), 283-286.
118. Miller, D.W.; Ahmad, R.; Hague, S.; Baptista, M.J.; Canet-Aviles, R.; McLendon, C.; Carter, D.M.; Zhu, P.P.; Stadler, J.; Chandran, J.; Klinefelter, G.R.; Blackstone, C.; Cookson, M.R. L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J. Biol. Chem., 2003, 278(38), 36588-36595.
119. Reddy, S.D.; Rayala, S.K.; Ohshiro, K.; Pakala, S.B.; Kobori, N.; Dash, P.; Yun, S.; Qin, J.; O'Malley, B.W.; Kumar, R. Multiple coregulatory control of tyrosine hydroxylase gene transcription. Proc. Natl. Acad. Sci. USA, 2011, 108(10), 4200-4205.
120. Taira, T.; Saito, Y.; Niki, T.; Iguchi-Ariga, S.M.; Takahashi, K.; Ariga, H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep., 2004, 5(2), 213-218.
121. Yanagida, T.; Kitamura, Y.; Yamane, K.; Takahashi, K.; Takata, K.; Yanagisawa, D.; Yasui, H.; Taniguchi, T.; Taira, T.; Honda, T.; Ariga, H. Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson's disease-linked PARK7. J. Pharmacol. Sci., 2009, 109(3), 463-468.
122. Yanagida, T.; Tsushima, J.; Kitamura, Y.; Yanagisawa, D.; Takata, K.; Shibaike, T.; Yamamoto, A.; Taniguchi, T.; Yasui, H.; Taira, T.; Morikawa, S.; Inubushi, T.; Tooyama, I.; Ariga, H. Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxid. Med. Cell Longev., 2009, 2(1), 36-42.
123. Zhong, N.; Kim, C.Y.; Rizzu, P.; Geula, C.; Porter, D.R.; Pothos, E.N.; Squitieri, F.; Heutink, P.; Xu, J. DJ-1 transcriptionally upregulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J. Biol. Chem., 2006, 281(30), 20940-20948.